Molecular Mechanisms Linking Exercise to Cancer Prevention and Treatment

Cell Metabolism

Volumn 27, Issue 1, 2018, Pages 10-21

  Hojman, Pernille ^a   Gehl, Julie ^b   Christensen, Jesper F ^a   Pedersen, Bente K ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b Mental Health Center Glostrup   (Denmark)

Author keywords

biomarkers; cancer; cancer therapy; cancer related depression; epinephrine; exercise training; immune surveillance; physical activity; tumor; tumor microenvironment

Indexed keywords

INTRINSIC FACTOR;

CACHEXIA; CANCER CELL; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER IMMUNOLOGY; CANCER INHIBITION; CANCER PREVENTION; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER THERAPY; CARCINOGENESIS; CELL METABOLISM; COGNITION; DEPRESSION; DRUG EFFICACY; EXERCISE; HUMAN; INFLAMMATION; MALIGNANT NEOPLASM; METABOLIC DISORDER; MOLECULAR BIOLOGY; MOLECULAR INTERACTION; MUSCLE DISEASE; NONHUMAN; OBESITY; PRIORITY JOURNAL; REVIEW; SKELETAL MUSCLE; BIOLOGICAL MODEL; GENETICS; IMMUNITY; NEOPLASM; PATHOLOGY; PHYSIOLOGY;

CARCINOGENESIS; EXERCISE; HUMANS; IMMUNITY; MODELS, BIOLOGICAL; NEOPLASMS;

EID: 85031826765     PISSN: 15504131     EISSN: 19327420     Source Type: Journal    
DOI: 10.1016/j.cmet.2017.09.015     Document Type: Review

References (109)

1. Agudelo, L.Z., Femenía, T., Orhan, F., Porsmyr-Palmertz, M., Goiny, M., Martinez-Redondo, V., Correia, J.C., Izadi, M., Bhat, M., Schuppe-Koistinen, I., et al. Skeletal muscle PGC-1α1 modulates kynurenine metabolism and mediates resilience to stress-induced depression. Cell 159 (2014), 33–45.
2. Angelin, A., Gil-de-Gómez, L., Dahiya, S., Jiao, J., Guo, L., Levine, M.H., Wang, Z., Quinn, W.J. 3rd, Kopinski, P.K., Wang, L., et al. Foxp3 reprograms T cell metabolism to function in low-glucose, high-lactate environments. Cell Metab. 25 (2017), 1282–1293.e7.
3. Aoi, W., Naito, Y., Takagi, T., Tanimura, Y., Takanami, Y., Kawai, Y., Sakuma, K., Hang, L.P., Mizushima, K., Hirai, Y., et al. A novel myokine, secreted protein acidic and rich in cysteine (SPARC), suppresses colon tumorigenesis via regular exercise. Gut 62 (2013), 882–889.
4. Arsenis, N.C., You, T., Ogawa, E.F., Tinsley, G.M., Zuo, L., Physical activity and telomere length: impact of aging and potential mechanisms of action. Oncotarget 8 (2017), 45008–45019.
5. Ashcraft, K.A., Peace, R.M., Betof, A.S., Dewhirst, M.W., Jones, L.W., Efficacy and mechanisms of aerobic exercise on cancer initiation, progression, and metastasis: a critical systematic review of in vivo preclinical data. Cancer Res. 76 (2016), 4032–4050.
6. Atherton, P.J., Babraj, J., Smith, K., Singh, J., Rennie, M.J., Wackerhage, H., Selective activation of AMPK-PGC-1alpha or PKB-TSC2-mTOR signaling can explain specific adaptive responses to endurance or resistance training-like electrical muscle stimulation. FASEB J. 19 (2005), 786–788.
7. Aveseh, M., Nikooie, R., Aminaie, M., Exercise-induced changes in tumour LDH-B and MCT1 expression are modulated by oestrogen-related receptor alpha in breast cancer-bearing BALB/c mice. J. Physiol. 593 (2015), 2635–2648.
8. Ballard-Barbash, R., Friedenreich, C.M., Courneya, K.S., Siddiqi, S.M., McTiernan, A., Alfano, C.M., Physical activity, biomarkers, and disease outcomes in cancer survivors: a systematic review. J. Natl. Cancer Inst. 104 (2012), 815–840.
9. Benatti, F.B., Pedersen, B.K., Exercise as an anti-inflammatory therapy for rheumatic diseases-myokine regulation. Nat. Rev. Rheumatol. 11 (2015), 86–97.
10. Betof, A.S., Lascola, C.D., Weitzel, D., Landon, C., Scarbrough, P.M., Devi, G.R., Palmer, G., Jones, L.W., Dewhirst, M.W., Modulation of murine breast tumor vascularity, hypoxia and chemotherapeutic response by exercise. J. Natl. Cancer Inst., 107, 2015, djv040.
11. Caruso, R., Nanni, M.G., Riba, M., Sabato, S., Mitchell, A.J., Croce, E., Grassi, L., Depressive spectrum disorders in cancer: prevalence, risk factors and screening for depression: a critical review. Acta Oncol. 56 (2017), 146–155.
12. Cavalheri V, Granger C. Preoperative exercise training for patients with non-small cell lung cancer. Cochrane Database of Systematic Reviews 2017(6),2017,CD012020.
13. Chen, H.H.W., Kuo, M.T., Improving radiotherapy in cancer treatment: Promises and challenges. Oncotarget 8 (2017), 62742–62758.
14. Chen, Q., Fisher, D.T., Clancy, K.A., Gauguet, J.M., Wang, W.C., Unger, E., Rose-John, S., von Andrian, U.H., Baumann, H., Evans, S.S., Fever-range thermal stress promotes lymphocyte trafficking across high endothelial venules via an interleukin 6 trans-signaling mechanism. Nat. Immunol. 7 (2006), 1299–1308.
15. Christensen, J.F., Jones, L.W., Andersen, J.L., Daugaard, G., Rorth, M., Hojman, P., Muscle dysfunction in cancer patients. Ann. Oncol. 25 (2014), 947–958.
16. Colbert, L.H., Westerlind, K.C., Perkins, S.N., Haines, D.C., Berrigan, D., Donehower, L.A., Fuchs-Young, R., Hursting, S.D., Exercise effects on tumorigenesis in a p53-deficient mouse model of breast cancer. Med. Sci. Sports Exerc. 41 (2009), 1597–1605.
17. Conlon, K.C., Lugli, E., Welles, H.C., Rosenberg, S.A., Fojo, A.T., Morris, J.C., Fleisher, T.A., Dubois, S.P., Perera, L.P., Stewart, D.M., et al. Redistribution, hyperproliferation, activation of natural killer cells and CD8 T cells, and cytokine production during first-in-human clinical trial of recombinant human interleukin-15 in patients with cancer. J. Clin. Oncol. 33 (2015), 74–82.
18. Cooney, G.M., Dwan, K., Greig, C.A., Lawlor, D.A., Rimer, J., Waugh, F.R., McMurdo, M., Mead, G.E., Exercise for depression. Cochrane Database Syst. Rev., 9, 2013, CD004366.
19. De Palma, M., Biziato, D., Petrova, T.V., Microenvironmental regulation of tumour angiogenesis. Nat. Rev. Cancer 17 (2017), 457–474.
20. DeBerardinis, R.J., Lum, J.J., Hatzivassiliou, G., Thompson, C.B., The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. Cell Metab. 7 (2008), 11–20.
21. Demark-Wahnefried, W., Campbell, K.L., Hayes, S.C., Weight management and its role in breast cancer rehabilitation. Cancer 118:8 Suppl (2012), 2277–2287.
22. Dethlefsen, C., Lillelund, C., Midtgaard, J., Andersen, C., Pedersen, B.K., Christensen, J.F., Hojman, P., Exercise regulates breast cancer cell viability: systemic training adaptations versus acute exercise responses. Breast Cancer Res. Treat. 159 (2016), 469–479.
23. Dethlefsen, C., Hansen, L.S., Lillelund, C., Andersen, C., Gehl, J., Christensen, J.F., Pedersen, B.K., Hojman, P., Exercise-induced catecholamines activate the hippo tumor suppressor pathway to reduce risks of breast cancer development. Cancer Res. 77 (2017), 4894–4904.
24. Dethlefsen, C., Pedersen, K.S., Hojman, P., Every exercise bout matters: linking systemic exercise responses to breast cancer control. Breast Cancer Res. Treat. 162 (2017), 399–408.
25. Evans, E.S., Hackney, A.C., McMurray, R.G., Randell, S.H., Muss, H.B., Deal, A.M., Battaglini, C.L., Impact of acute intermittent exercise on natural killer cells in breast cancer survivors. Integr. Cancer Ther. 14 (2015), 436–445.
26. Evans, S.S., Repasky, E.A., Fisher, D.T., Fever and the thermal regulation of immunity: the immune system feels the heat. Nat. Rev. Immunol. 15 (2015), 335–349.
27. Fearon, K., Arends, J., Baracos, V., Understanding the mechanisms and treatment options in cancer cachexia. Nat. Rev. Clin. Oncol. 10 (2013), 90–99.
28. Ferrone, C., Dranoff, G., Dual roles for immunity in gastrointestinal cancers. J. Clin. Oncol. 28 (2010), 4045–4051.
29. Fischer, K., Hoffmann, P., Voelkl, S., Meidenbauer, N., Ammer, J., Edinger, M., Gottfried, E., Schwarz, S., Rothe, G., Hoves, S., et al. Inhibitory effect of tumor cell-derived lactic acid on human T cells. Blood 109 (2007), 3812–3819.
30. Fisher, D.T., Chen, Q., Skitzki, J.J., Muhitch, J.B., Zhou, L., Appenheimer, M.M., Vardam, T.D., Weis, E.L., Passanese, J., Wang, W.C., et al. IL-6 trans-signaling licenses mouse and human tumor microvascular gateways for trafficking of cytotoxic T cells. J. Clin. Invest. 121 (2011), 3846–3859.
31. Friedenreich, C.M., O'Reilly, R., Shaw, E., Stanczyk, F.Z., Yasui, Y., Brenner, D.R., Courneya, K.S., Inflammatory marker changes in postmenopausal women after a year-long exercise intervention comparing high versus moderate volumes. Cancer Prev. Res. (Phila.) 9 (2016), 196–203.
32. Gabriel, B.M., Zierath, J.R., The limits of exercise physiology: from performance to health. Cell Metab. 25 (2017), 1000–1011.
33. Gabriel, B.M., Hamilton, D.L., Tremblay, A.M., Wackerhage, H., The Hippo signal transduction network for exercise physiologists. J. Appl. Physiol. 120 (2016), 1105–1117.
34. Gallot, Y.S., Durieux, A.C., Castells, J., Desgeorges, M.M., Vernus, B., Plantureux, L., Rémond, D., Jahnke, V.E., Lefai, E., Dardevet, D., et al. Myostatin gene inactivation prevents skeletal muscle wasting in cancer. Cancer Res. 74 (2014), 7344–7356.
35. Galvão, D.A., Taaffe, D.R., Spry, N., Joseph, D., Newton, R.U., Combined resistance and aerobic exercise program reverses muscle loss in men undergoing androgen suppression therapy for prostate cancer without bone metastases: a randomized controlled trial. J. Clin. Oncol. 28 (2010), 340–347.
36. Gannon, N.P., Vaughan, R.A., Garcia-Smith, R., Bisoffi, M., Trujillo, K.A., Effects of the exercise-inducible myokine irisin on malignant and non-malignant breast epithelial cell behavior in vitro. Int. J. Cancer 136 (2015), E197–E202.
37. Gao, S., Zheng, M., Ren, X., Tang, Y., Liang, X., Local hyperthermia in head and neck cancer: mechanism, application and advance. Oncotarget 7 (2016), 57367–57378.
38. Garcia, E., Becker, V.G., McCullough, D.J., Stabley, J.N., Gittemeier, E.M., Opoku-Acheampong, A.B., Sieman, D.W., Behnke, B.J., Blood flow responses to mild-intensity exercise in ectopic vs. orthotopic prostate tumors; dependence upon host tissue hemodynamics and vascular reactivity. J. Appl. Physiol. 121 (2016), 15–24.
39. González-Alonso, J., Human thermoregulation and the cardiovascular system. Exp. Physiol. 97 (2012), 340–346.
40. Gross, E., Sunwoo, J.B., Bui, J.D., Cancer immunosurveillance and immunoediting by natural killer cells. Cancer J. 19 (2013), 483–489.
41. Hawley, J.A., Hargreaves, M., Joyner, M.J., Zierath, J.R., Integrative biology of exercise. Cell 159 (2014), 738–749.
42. Henningsen, J., Rigbolt, K.T., Blagoev, B., Pedersen, B.K., Kratchmarova, I., Dynamics of the skeletal muscle secretome during myoblast differentiation. Mol. Cell. Proteomics 9 (2010), 2482–2496.
43. Hersey, P., Watts, R.N., Zhang, X.D., Hackett, J., Metabolic approaches to treatment of melanoma. Clin. Cancer Res. 15 (2009), 6490–6494.
44. Higgins, K.A., Park, D., Lee, G.Y., Curran, W.J., Deng, X., Exercise-induced lung cancer regression: mechanistic findings from a mouse model. Cancer 120 (2014), 3302–3310.
45. Hojman, P., Dethlefsen, C., Brandt, C., Hansen, J., Pedersen, L., Pedersen, B.K., Exercise-induced muscle-derived cytokines inhibit mammary cancer cell growth. Am. J. Physiol. Endocrinol. Metab. 301 (2011), E504–E510.
46. Hojman, P., Fjelbye, J., Zerahn, B., Christensen, J.F., Dethlefsen, C., Lonkvist, C.K., Brandt, C., Gissel, H., Pedersen, B.K., Gehl, J., Voluntary exercise prevents cisplatin-induced muscle wasting during chemotherapy in mice. PLoS One, 9, 2014, e109030.
47. Holmes, M.D., Chen, W.Y., Feskanich, D., Kroenke, C.H., Colditz, G.A., Physical activity and survival after breast cancer diagnosis. JAMA 293 (2005), 2479–2486.
48. Horowitz, M., Neeman, E., Sharon, E., Ben-Eliyahu, S., Exploiting the critical perioperative period to improve long-term cancer outcomes. Nat. Rev. Clin. Oncol. 12 (2015), 213–226.
49. Hvid, T., Winding, K., Rinnov, A., Dejgaard, T., Thomsen, C., Iversen, P., Brasso, K., Mikines, K.J., van Hall, G., Lindegaard, B., et al. Endurance training improves insulin sensitivity and body composition in prostate cancer patients treated with androgen deprivation therapy. Endocr. Relat. Cancer 20 (2013), 621–632.
50. Idorn, M., Hojman, P., Exercise-dependent regulation of NK cells in cancer protection. Trends Mol. Med. 22 (2016), 565–577.
51. Imayama, I., Ulrich, C.M., Alfano, C.M., Wang, C., Xiao, L., Wener, M.H., Campbell, K.L., Duggan, C., Foster-Schubert, K.E., Kong, A., et al. Effects of a caloric restriction weight loss diet and exercise on inflammatory biomarkers in overweight/obese postmenopausal women: a randomized controlled trial. Cancer Res. 72 (2012), 2314–2326.
52. Jiang, W., Zhu, Z., Thompson, H.J., Effects of limiting energy availability via diet and physical activity on mammalian target of rapamycin-related signaling in rat mammary carcinomas. Carcinogenesis 34 (2013), 378–387.
53. Jones, S.B., Thomas, G.A., Hesselsweet, S.D., Alvarez-Reeves, M., Yu, H., Irwin, M.L., Effect of exercise on markers of inflammation in breast cancer survivors: the Yale exercise and survivorship study. Cancer Prev. Res. (Phila.) 6 (2013), 109–118.
54. Jones, L.W., Kwan, M.L., Weltzien, E., Chandarlapaty, S., Sternfeld, B., Sweeney, C., Bernard, P.S., Castillo, A., Habel, L.A., Kroenke, C.H., et al. Exercise and prognosis on the basis of clinicopathologic and molecular features in early-stage breast cancer: the LACE and pathways studies. Cancer Res. 76 (2016), 5415–5422.
55. Kenfield, S.A., Stampfer, M.J., Giovannucci, E., Chan, J.M., Physical activity and survival after prostate cancer diagnosis in the health professionals follow-up study. J. Clin. Oncol. 29 (2011), 726–732.
56. Kim, S., Miller, B.J., Stefanek, M.E., Miller, A.H., Inflammation-induced activation of the indoleamine 2,3-dioxygenase pathway: relevance to cancer-related fatigue. Cancer 121 (2015), 2129–2136.
57. Kir, S., White, J.P., Kleiner, S., Kazak, L., Cohen, P., Baracos, V.E., Spiegelman, B.M., Tumour-derived PTH-related protein triggers adipose tissue browning and cancer cachexia. Nature 513 (2014), 100–104.
58. Kir, S., Komaba, H., Garcia, A.P., Economopoulos, K.P., Liu, W., Lanske, B., Hodin, R.A., Spiegelman, B.M., PTH/PTHrP receptor mediates cachexia in models of kidney failure and cancer. Cell Metab. 23 (2016), 315–323.
59. Klil-Drori, A.J., Azoulay, L., Pollak, M.N., Cancer, obesity, diabetes, and antidiabetic drugs: is the fog clearing?. Nat. Rev. Clin. Oncol. 14 (2017), 85–99.
60. Kurgan, N., Tsakiridis, E., Kouvelioti, R., Moore, J., Klentrou, P., Tsiani, E., Inhibition of human lung cancer cell proliferation and survival by post-exercise serum is associated with the inhibition of Akt, mTOR, p70 S6K, and Erk1/2. Cancers (Basel), 9, 2017, E46.
61. Lee, C., Safdie, F.M., Raffaghello, L., Wei, M., Madia, F., Parrella, E., Hwang, D., Cohen, P., Bianchi, G., Longo, V.D., Reduced levels of IGF-I mediate differential protection of normal and cancer cells in response to fasting and improve chemotherapeutic index. Cancer Res. 70 (2010), 1564–1572.
62. Lin, C., Clark, R., Tu, P., Bosworth, H.B., Zullig, L.L., Breast cancer oral anti-cancer medication adherence: a systematic review of psychosocial motivators and barriers. Breast Cancer Res. Treat. 165 (2017), 247–260.
63. Lu, Y.P., Lou, Y.R., Nolan, B., Peng, Q.Y., Xie, J.G., Wagner, G.C., Conney, A.H., Stimulatory effect of voluntary exercise or fat removal (partial lipectomy) on apoptosis in the skin of UVB light-irradiated mice. Proc. Natl. Acad. Sci. USA 103 (2006), 16301–16306.
64. Marçais, A., Cherfils-Vicini, J., Viant, C., Degouve, S., Viel, S., Fenis, A., Rabilloud, J., Mayol, K., Tavares, A., Bienvenu, J., et al. The metabolic checkpoint kinase mTOR is essential for IL-15 signaling during the development and activation of NK cells. Nat. Immunol. 15 (2014), 749–757.
65. Martinez-Outschoorn, U.E., Peiris-Pagés, M., Pestell, R.G., Sotgia, F., Lisanti, M.P., Cancer metabolism: a therapeutic perspective. Nat. Rev. Clin. Oncol. 14 (2017), 11–31.
66. McCullough, D.J., Nguyen, L.M., Siemann, D.W., Behnke, B.J., Effects of exercise training on tumor hypoxia and vascular function in the rodent preclinical orthotopic prostate cancer model. J. Appl. Physiol. 115 (2013), 1846–1854.
67. McCullough, D.J., Stabley, J.N., Siemann, D.W., Behnke, B.J., Modulation of blood flow, hypoxia, and vascular function in orthotopic prostate tumors during exercise. J. Natl. Cancer Inst., 106, 2014, dju036.
68. McTiernan, A., Mechanisms linking physical activity with cancer. Nat. Rev. Cancer 8 (2008), 205–211.
69. Meyerhardt, J.A., Giovannucci, E.L., Holmes, M.D., Chan, A.T., Chan, J.A., Colditz, G.A., Fuchs, C.S., Physical activity and survival after colorectal cancer diagnosis. J. Clin. Oncol. 24 (2006), 3527–3534.
70. Mishra, S.I., Scherer, R.W., Geigle, P.M., Berlanstein, D.R., Topaloglu, O., Gotay, C.C., Snyder, C., Exercise interventions on health-related quality of life for cancer survivors. Cochrane Database Syst. Rev., 8, 2012, CD007566.
71. Mishra, S.I., Scherer, R.W., Snyder, C., Geigle, P.M., Berlanstein, D.R., Topaloglu, O., Exercise interventions on health-related quality of life for people with cancer during active treatment. Cochrane Database Syst. Rev., 2012, 10.1002/14651858.CD008465.pub2.
72. Mitsuishi, Y., Taguchi, K., Kawatani, Y., Shibata, T., Nukiwa, T., Aburatani, H., Yamamoto, M., Motohashi, H., Nrf2 redirects glucose and glutamine into anabolic pathways in metabolic reprogramming. Cancer Cell 22 (2012), 66–79.
73. Moore, S.C., Lee, I.M., Weiderpass, E., Campbell, P.T., Sampson, J.N., Kitahara, C.M., Keadle, S.K., Arem, H., Berrington de Gonzalez, A., Hartge, P., et al. Association of leisure-time physical activity with risk of 26 types of cancer in 1.44 million adults. JAMA Intern. Med. 176 (2016), 816–825.
74. Morikawa, T., Kuchiba, A., Yamauchi, M., Meyerhardt, J.A., Shima, K., Nosho, K., Chan, A.T., Giovannucci, E., Fuchs, C.S., Ogino, S., Association of CTNNB1 (beta-catenin) alterations, body mass index, and physical activity with survival in patients with colorectal cancer. JAMA 305 (2011), 1685–1694.
75. Müller, L., Aigner, P., Stoiber, D., Type I interferons and natural killer cell regulation in cancer. Front. Immunol., 8, 2017, 304.
76. Nair, S., Ren, J., Autophagy and cardiovascular aging: lesson learned from rapamycin. Cell Cycle 11 (2012), 2092–2099.
77. Nelson, B.H., The impact of T-cell immunity on ovarian cancer outcomes. Immunol. Rev. 222 (2008), 101–116.
78. Neufer, P.D., Bamman, M.M., Muoio, D.M., Bouchard, C., Cooper, D.M., Goodpaster, B.H., Booth, F.W., Kohrt, W.M., Gerszten, R.E., Mattson, M.P., et al. Understanding the cellular and molecular mechanisms of physical activity-induced health benefits. Cell Metab. 22 (2015), 4–11.
79. Newby, T.A., Graff, J.N., Ganzini, L.K., McDonagh, M.S., Interventions that may reduce depressive symptoms among prostate cancer patients: a systematic review and meta-analysis. Psychooncology 24 (2015), 1686–1693.
80. Nilsen, T.S., Thorsen, L., Fosså S.D., Wiig, M., Kirkegaard, C., Skovlund, E., Benestad, H.B., Raastad, T., Effects of strength training on muscle cellular outcomes in prostate cancer patients on androgen deprivation therapy. Scand. J. Med. Sci. Sports 26 (2016), 1026–1035.
81. Pagès, F., Galon, J., Dieu-Nosjean, M.C., Tartour, E., Sautès-Fridman, C., Fridman, W.H., Immune infiltration in human tumors: a prognostic factor that should not be ignored. Oncogene 29 (2010), 1093–1102.
82. Park, J., Morley, T.S., Kim, M., Clegg, D.J., Scherer, P.E., Obesity and cancer–mechanisms underlying tumour progression and recurrence. Nat. Rev. Endocrinol. 10 (2014), 455–465.
83. Pedersen, B.K., Febbraio, M.A., Muscle as an endocrine organ: focus on muscle-derived interleukin-6. Physiol. Rev. 88 (2008), 1379–1406.
84. Pedersen, B.K., Febbraio, M.A., Muscles, exercise and obesity: skeletal muscle as a secretory organ. Nat. Rev. Endocrinol. 8 (2012), 457–465.
85. Pedersen, B.K., Saltin, B., Exercise as medicine - evidence for prescribing exercise as therapy in 26 different chronic diseases. Scand. J. Med. Sci. Sports 25:Suppl 3 (2015), 1–72.
86. Pedersen, L., Christensen, J.F., Hojman, P., Effects of exercise on tumor physiology and metabolism. Cancer J. 21 (2015), 111–116.
87. Pedersen, L., Idorn, M., Olofsson, G.H., Lauenborg, B., Nookaew, I., Hansen, R.H., Johannesen, H.H., Becker, J.C., Pedersen, K.S., Dethlefsen, C., et al. Voluntary running suppresses tumor growth through epinephrine- and IL-6-dependent NK cell mobilization and redistribution. Cell Metab. 23 (2016), 554–562.
88. Piguet, A.C., Saran, U., Simillion, C., Keller, I., Terracciano, L., Reeves, H.L., Dufour, J.F., Regular exercise decreases liver tumors development in hepatocyte-specific PTEN-deficient mice independently of steatosis. J. Hepatol. 62 (2015), 1296–1303.
89. Rundqvist, H., Augsten, M., Strömberg, A., Rullman, E., Mijwel, S., Kharaziha, P., Panaretakis, T., Gustafsson, T., Östman, A., Effect of acute exercise on prostate cancer cell growth. PLoS One, 8, 2013, e67579.
90. Sasso, J.P., Eves, N.D., Christensen, J.F., Koelwyn, G.J., Scott, J., Jones, L.W., A framework for prescription in exercise-oncology research. J. Cachexia Sarcopenia Muscle 6 (2015), 115–124.
91. Satoh-Takayama, N., Lesjean-Pottier, S., Vieira, P., Sawa, S., Eberl, G., Vosshenrich, C.A., Di Santo, J.P., IL-7 and IL-15 independently program the differentiation of intestinal CD3-NKp46+ cell subsets from Id2-dependent precursors. J. Exp. Med. 207 (2010), 273–280.
92. Schadler, K.L., Thomas, N.J., Galie, P.A., Bhang, D.H., Roby, K.C., Addai, P., Till, J.E., Sturgeon, K., Zaslavsky, A., Chen, C.S., Ryeom, S., Tumor vessel normalization after aerobic exercise enhances chemotherapeutic efficacy. Oncotarget 7 (2016), 65429–65440.
93. Schiaffino, S., Dyar, K.A., Ciciliot, S., Blaauw, B., Sandri, M., Mechanisms regulating skeletal muscle growth and atrophy. FEBS J. 280 (2013), 4294–4314.
94. Schlittler, M., Goiny, M., Agudelo, L.Z., Venckunas, T., Brazaitis, M., Skurvydas, A., Kamandulis, S., Ruas, J.L., Erhardt, S., Westerblad, H., Andersson, D.C., Endurance exercise increases skeletal muscle kynurenine aminotransferases and plasma kynurenic acid in humans. Am. J. Physiol. Cell Physiol. 310 (2016), C836–C840.
95. Schmitz, K.H., Courneya, K.S., Matthews, C., Demark-Wahnefried, W., Galvão, D.A., Pinto, B.M., Irwin, M.L., Wolin, K.Y., Segal, R.J., Lucia, A., et al., American College of Sports Medicine. American College of Sports Medicine roundtable on exercise guidelines for cancer survivors. Med. Sci. Sports Exerc. 42 (2010), 1409–1426.
96. Schneider, G., Schmidt-Supprian, M., Rad, R., Saur, D., Tissue-specific tumorigenesis: context matters. Nat. Rev. Cancer 17 (2017), 239–253.
97. Sharma, P., Allison, J.P., Immune checkpoint targeting in cancer therapy: toward combination strategies with curative potential. Cell 161 (2015), 205–214.
98. Singh, F., Newton, R.U., Galvão, D.A., Spry, N., Baker, M.K., A systematic review of pre-surgical exercise intervention studies with cancer patients. Surg. Oncol. 22 (2013), 92–104.
99. Strauss, D.C., Thomas, J.M., Transmission of donor melanoma by organ transplantation. Lancet Oncol. 11 (2010), 790–796.
100. Tarrado-Castellarnau, M., de Atauri, P., Cascante, M., Oncogenic regulation of tumor metabolic reprogramming. Oncotarget 7 (2016), 62726–62753.
101. Tasdemir, N., Banito, A., Roe, J.S., Alonso-Curbelo, D., Camiolo, M., Tschaharganeh, D.F., Huang, C.H., Aksoy, O., Bolden, J.E., Chen, C.C., et al. BRD4 connects enhancer remodeling to senescence immune surveillance. Cancer Discov. 6 (2016), 612–629.
102. Theriau, C.F., Shpilberg, Y., Riddell, M.C., Connor, M.K., Voluntary physical activity abolishes the proliferative tumor growth microenvironment created by adipose tissue in animals fed a high fat diet. J. Appl. Physiol. 121 (2016), 139–153.
103. Thompson, H.J., Jiang, W., Zhu, Z., Candidate mechanisms accounting for effects of physical activity on breast carcinogenesis. IUBMB Life 61 (2009), 895–901.
104. Tremblay, A.M., Missiaglia, E., Galli, G.G., Hettmer, S., Urcia, R., Carrara, M., Judson, R.N., Thway, K., Nadal, G., Selfe, J.L., et al. The Hippo transducer YAP1 transforms activated satellite cells and is a potent effector of embryonal rhabdomyosarcoma formation. Cancer Cell 26 (2014), 273–287.
105. van Gemert, W.A., Monninkhof, E.M., May, A.M., Elias, S.G., van der Palen, J., Veldhuis, W., Stapper, M., Stellato, R.K., Schuit, J.A., Peeters, P.H., Association between changes in fat distribution and biomarkers for breast cancer. Endocr. Relat. Cancer 24 (2017), 297–305.
106. Wall, B.A., GALVãO, D.A., Fatehee, N., Taaffe, D.R., Spry, N., Joseph, D., Hebert, J.J., Newton, R.U., Exercise improves V˙O2max and body composition in androgen deprivation therapy-treated prostate cancer patients. Med. Sci. Sports Exerc. 49 (2017), 1503–1510.
107. Whitham, M., Febbraio, M.A., The ever-expanding myokinome: discovery challenges and therapeutic implications. Nat. Rev. Drug Discov. 15 (2016), 719–729.
108. Yu, F.X., Zhao, B., Panupinthu, N., Jewell, J.L., Lian, I., Wang, L.H., Zhao, J., Yuan, H., Tumaneng, K., Li, H., et al. Regulation of the Hippo-YAP pathway by G-protein-coupled receptor signaling. Cell 150 (2012), 780–791.
109. Zanconato, F., Cordenonsi, M., Piccolo, S., YAP/TAZ at the roots of cancer. Cancer Cell 29 (2016), 783–803.